Opportunities for the repurposing of PARP inhibitors for the therapy of non‐oncological diseases
Nathan A. Berger(University School), Csaba Szabó(University of Fribourg), Ted M. Dawson(Johns Hopkins University), Alexander Bürkle(University of Konstanz), Raymond A. Swanson(San Francisco VA Medical Center), Balázs Sümegi(University of Szeged), Flavio Moroni(University of Florence), Valina L. Dawson(Johns Hopkins University), Alberto Chiarugi(Azienda Ospedaliero-Universitaria Careggi), György Haskó(Columbia University), Robert S. B. Clark(Children's Hospital of Pittsburgh), Lucas Liaudet(University Hospital of Lausanne), Valérie C. Besson(Inserm), Salvatore Cuzzocrea(University of Messina), Francisco García Soriano(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo), A. Hamid Boulares(Louisiana State University Health Sciences Center New Orleans), Robert P. Strosznajder(Mossakowski Medical Research Institute, Polish Academy of Sciences), Pál Pacher(National Institutes of Health), Peter Radermacher(Universität Ulm), Nicola J. Curtin(Newcastle University), Andrew L. Salzman(BD Biosciences (United States)), Solomon H. Snyder(Johns Hopkins University)
Cited by 210
Related Papers
Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes
|Autophagy|2008|2k
Post-cardiac arrest syndrome: Epidemiology, pathophysiology, treatment, and prognostication
|Resuscitation|2008|1.5k
Post–Cardiac Arrest Syndrome
|Circulation|2008|1.4k
Exercise is the Real Polypill
|Physiology|2013|779
Poly(ADP-Ribose) in the Cellular Response to DNA Damage
|Radiation Research|1985|775